Key facts
- Kouper’s last known valuation is $12.0M (Feb 2023).
- It has raised $13.5M; the latest was Early Stage VC ($10.0M) in May 2025.
- Notable investors include General Catalyst, 25madison, CVS Health Ventures, 25m Health.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Kouper
- ·The full record, as it builds
Funding rounds
No funding rounds for Kouper are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kouper
Developer of a health technology platform designed to improve health outcomes by connecting patients with timely access to care. The company's platform offers connectivity between acute, post-acute, and primary care for outcomes, and develops patient recuperation to recover and restore, enabling care teams to personalize support and utilize value-oriented care management programs.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2021
- Employees
- 19
- Website
- kouperhealth.com/
- Ownership
- Privately Held (backing)
Kouper doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kouper shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kouper in its N-PORT filings yet. We sweep new filings monthly.